{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:38:55Z","timestamp":1787319535270,"version":"build-2736575974"},"reference-count":86,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology","award":["MOST 107-2320-B-037-003"],"award-info":[{"award-number":["MOST 107-2320-B-037-003"]}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TP105E12"],"award-info":[{"award-number":["KMU-TP105E12"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["105KMUOR05"],"award-info":[{"award-number":["105KMUOR05"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-O104003"],"award-info":[{"award-number":["KMU-O104003"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CCH-KMU Research Project","award":["105-CCH-KMU-005"],"award-info":[{"award-number":["105-CCH-KMU-005"]}]},{"name":"NSYSU-KMU Research Project","award":["NSYSUKMU106-P011"],"award-info":[{"award-number":["NSYSUKMU106-P011"]}]},{"name":"Taiwan Protein Project","award":["AS-KPQ-105-TPP"],"award-info":[{"award-number":["AS-KPQ-105-TPP"]}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jfda.2018.11.009","type":"journal-article","created":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T02:24:15Z","timestamp":1547259855000},"page":"551-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Reduction of aluminum ion neurotoxicity through a small peptide application \u2013 NAP treatment of Alzheimer's disease"],"prefix":"10.38212","volume":"27","author":[{"given":"Ming-Hui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yii","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Chin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illana","family":"Gozes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1917-5893","authenticated-orcid":false,"given":"Yu-Chang","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2018.11.009_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jnen\/60.10.923","article-title":"Alzheimer disease therapeutics","volume":"60","author":"Irizarry","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jfda.2018.11.009_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfda.2018.11.009_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","article-title":"Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease","volume":"19","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jfda.2018.11.009_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2478\/intox-2014-0009","article-title":"Toxicity, mechanism and health effects of some heavy metals","volume":"7","author":"Jaishankar","year":"2014","journal-title":"Interdiscip Toxicol"},{"key":"10.1016\/j.jfda.2018.11.009_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary tau species are potential biomarkers of Alzheimer disease","volume":"27","author":"Shi","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfda.2018.11.009_bib6","first-page":"1","article-title":"Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study","volume":"29","author":"Zabel","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfda.2018.11.009_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3233\/JAD-2010-1303","article-title":"The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease","volume":"19","author":"Mueller","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfda.2018.11.009_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000330750","article-title":"A blood-based algorithm for the detection of Alzheimer's disease","volume":"32","author":"O'Bryant","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jfda.2018.11.009_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2010.08.018","article-title":"Olfactory deficit detected by fMRI in early Alzheimer's disease","volume":"1357","author":"Wang","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.jfda.2018.11.009_bib10","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer's disease","volume":"129","author":"Hye","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jfda.2018.11.009_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-010-0680-3","article-title":"CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy","volume":"119","author":"Zilka","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jfda.2018.11.009_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","article-title":"Blood-based biomarkers of microvascular pathology in Alzheimer's disease","volume":"45","author":"Ewers","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jfda.2018.11.009_bib13","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.jprot.2012.04.017","article-title":"Activity-dependent neuroprotector homeobox protein: a candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease","volume":"75","author":"Yang","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.jfda.2018.11.009_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JAD-150799","article-title":"Blood-borne activity-dependent neuroprotective protein (ADNP) is correlated with premorbid intelligence, clinical stage, and alzheimer's disease biomarkers","volume":"50","author":"Malishkevich","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfda.2018.11.009_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","article-title":"Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide","volume":"72","author":"Bassan","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.jfda.2018.11.009_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1074\/jbc.M007416200","article-title":"Cloning and characterization of the human activity-dependent neuroprotective protein","volume":"276","author":"Zamostiano","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfda.2018.11.009_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-3806(03)00162-7","article-title":"Activity-dependent neuroprotective protein: a novel gene essential for brain formation","volume":"144","author":"Pinhasov","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.jfda.2018.11.009_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.107.129551","article-title":"Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model","volume":"323","author":"Vulih-Shultzman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfda.2018.11.009_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12031-009-9300-x","article-title":"Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein\/presenilin 1 mouse model of Alzheimer's disease","volume":"41","author":"Fernandez-Montesinos","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jfda.2018.11.009_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.32725\/jab.2005.008","article-title":"Neuroprotective peptides as drug candidates against Alzheimer's disease","volume":"3","author":"Patocka","year":"2005","journal-title":"J Appl Biomed"},{"key":"10.1016\/j.jfda.2018.11.009_bib21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ydbio.2006.11.039","article-title":"Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis","volume":"303","author":"Mandel","year":"2007","journal-title":"Dev Biol"},{"key":"10.1016\/j.jfda.2018.11.009_bib22","doi-asserted-by":"crossref","first-page":"34448","DOI":"10.1074\/jbc.M704756200","article-title":"Activity-dependent neuroprotective protein constitutes a novel element in the SWI\/SNF chromatin remodeling complex","volume":"282","author":"Mandel","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfda.2018.11.009_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41586-018-0153-8","article-title":"Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes","volume":"557","author":"Ostapcuk","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jfda.2018.11.009_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/mp.2015.208","article-title":"Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory","volume":"21","author":"Amram","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jfda.2018.11.009_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2006.03.029","article-title":"Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress","volume":"252","author":"Steingart","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jfda.2018.11.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-9-S3-S3","article-title":"NAP and D-SAL: neuroprotection against the \u03b2 amyloid peptide (1\u201342)","volume":"9","author":"Gozes","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.jfda.2018.11.009_bib27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.peptides.2003.08.005","article-title":"The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide","volume":"24","author":"Ashur-Fabian","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.jfda.2018.11.009_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1567205053585873","article-title":"The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury","volume":"2","author":"Gozes","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.jfda.2018.11.009_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00417-007-0746-7","article-title":"The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush","volume":"246","author":"Jehle","year":"2008","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfda.2018.11.009_bib30","doi-asserted-by":"crossref","first-page":"28531","DOI":"10.1074\/jbc.M403197200","article-title":"A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication","volume":"279","author":"Divinski","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfda.2018.11.009_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1471-4159.2006.03936.x","article-title":"Peptide neuroprotection through specific interaction with brain tubulin","volume":"98","author":"Divinski","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.jfda.2018.11.009_bib32","doi-asserted-by":"crossref","first-page":"e51458","DOI":"10.1371\/journal.pone.0051458","article-title":"The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities","volume":"7","author":"Oz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2018.11.009_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/mp.2014.97","article-title":"The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins","volume":"19","author":"Oz","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jfda.2018.11.009_bib34","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/mp.2016.255","article-title":"ADNP\/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy","volume":"22","author":"Ivashko-Pachima","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jfda.2018.11.009_bib35","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.2174\/0929867321666140217124945","article-title":"Davunetide: peptide therapeutic in neurological disorders","volume":"21","author":"Magen","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jfda.2018.11.009_bib36","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1073\/pnas.1331636100","article-title":"Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity","volume":"100","author":"Wilkemeyer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfda.2018.11.009_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3233\/JAD-2010-1335","article-title":"The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules","volume":"19","author":"Yenjerla","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfda.2018.11.009_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidativeinsults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jfda.2018.11.009_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-0115(00)00198-1","article-title":"A Novel peptide prevents death in enriched neuronal cultures","volume":"96","author":"Zemlyak","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.jfda.2018.11.009_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-\u03b2","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jfda.2018.11.009_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of alzheimer's disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfda.2018.11.009_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fnmol.2018.00151","article-title":"ADNP, a microtubule interacting protein, provides neuroprotection through end binding proteins and tau: an amplifier effect","volume":"11","author":"Gozes","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jfda.2018.11.009_bib43","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1074\/mcp.M112.025585","article-title":"Quantitative assessment of in-solution digestion efficiency identifies optimal protocols for unbiased protein analysis","volume":"12","author":"Le\u00f3n","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jfda.2018.11.009_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/mp.2013.174","article-title":"Autophagy has a key role in the pathophysiology of schizophrenia","volume":"20","author":"Merenlender-Wagner","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jfda.2018.11.009_bib45","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4161\/15548627.2014.984274","article-title":"New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia","volume":"10","author":"Merenlender-Wagner","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.jfda.2018.11.009_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbadis.2013.10.003","article-title":"The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease","volume":"1842","author":"Esteves","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jfda.2018.11.009_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0361-9230(01)00475-0","article-title":"Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein","volume":"55","author":"Kawahara","year":"2001","journal-title":"Brain Res Bull"},{"issue":"Suppl. 1","key":"10.1016\/j.jfda.2018.11.009_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10937400701597766","article-title":"Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide","volume":"10","author":"Krewski","year":"2007","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.jfda.2018.11.009_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12011-009-8490-y","article-title":"Protective role of melatonin on oxidative stress status and RNA expression in cerebral cortex and cerebellum of AbetaPP transgenic mice after chronic exposure to aluminum","volume":"135","author":"Garcia","year":"2010","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.jfda.2018.11.009_bib50","first-page":"1138","article-title":"Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice","volume":"16","author":"Pratico","year":"2002","journal-title":"FASEB J \u2013 Offic Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.jfda.2018.11.009_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10534-005-6965-7","article-title":"Memory deficit in mice administered aluminum-maltolate complex","volume":"19","author":"Kaneko","year":"2006","journal-title":"Biometals \u2013Int J Role Metal Ions Biol Biochem Med"},{"key":"10.1016\/j.jfda.2018.11.009_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuro.2008.11.012","article-title":"Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents","volume":"30","author":"Walton","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jfda.2018.11.009_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2006.08.093","article-title":"A longitudinal study of rats chronically exposed to aluminum at human dietary levels","volume":"412","author":"Walton","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jfda.2018.11.009_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neuro.2008.08.005","article-title":"Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats","volume":"29","author":"Sethi","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jfda.2018.11.009_bib55","first-page":"433","article-title":"Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain","volume":"23","author":"Rodella","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jfda.2018.11.009_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jfda.2018.11.009_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","article-title":"A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade","volume":"91","author":"Wirths","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.jfda.2018.11.009_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.etap.2011.12.005","article-title":"The profile of beta-amyloid precursor protein expression of rats induced by aluminum","volume":"33","author":"Li","year":"2012","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jfda.2018.11.009_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2008.08.017","article-title":"Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease","volume":"214","author":"Ribes","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jfda.2018.11.009_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neulet.2008.05.070","article-title":"Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin","volume":"440","author":"Lin","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jfda.2018.11.009_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1525-1373.2000.22356.x","article-title":"Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells","volume":"223","author":"Campbell","year":"2000","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med"},{"key":"10.1016\/j.jfda.2018.11.009_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10565-009-9149-3","article-title":"Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity","volume":"26","author":"Castorina","year":"2010","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.jfda.2018.11.009_bib63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuroscience.2010.10.074","article-title":"Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy","volume":"173","author":"Sokolowska","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jfda.2018.11.009_bib64","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2174\/138161211797416093","article-title":"Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects","volume":"17","author":"Shiryaev","year":"2011","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jfda.2018.11.009_bib65","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2202-9-S3-S3","article-title":"NAP and D-SAL: neuroprotection against the beta amyloid peptide (1\u201342)","volume":"9","author":"Gozes","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.jfda.2018.11.009_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/JMN\/31:02:165","article-title":"Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage","volume":"31","author":"Matsuoka","year":"2007","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jfda.2018.11.009_bib67","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138161211795589373","article-title":"NAP (davunetide) provides functional and structural neuroprotection","volume":"17","author":"Gozes","year":"2011","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jfda.2018.11.009_bib68","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/mp.2013.32","article-title":"NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy","volume":"18","author":"Quraishe","year":"2013","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.jfda.2018.11.009_bib69","first-page":"493670","article-title":"Tau and caspase 3 as targets for neuroprotection","volume":"2012","author":"Idan-Feldman","year":"2012","journal-title":"Int J Alzheimer's Dis"},{"key":"10.1016\/j.jfda.2018.11.009_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087383","article-title":"Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation","volume":"9","author":"Schirer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2018.11.009_bib71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00702-003-0096-5","article-title":"Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function","volume":"111","author":"Kennedy","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jfda.2018.11.009_bib72","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2011.09.136","article-title":"Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line","volume":"414","author":"Sung","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jfda.2018.11.009_bib73","first-page":"9925","article-title":"Leucine-rich repeat neuronal protein 4 (LRRN4) potentially functions in dilated cardiomyopathy","volume":"10","author":"Li","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jfda.2018.11.009_bib74","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1128\/MCB.25.10.4166-4175.2005","article-title":"Neuronal leucine-rich repeat protein 4 functions in hippocampus-dependent long-lasting memory","volume":"25","author":"Bando","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jfda.2018.11.009_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025391","article-title":"LRRN4 and UPK3B are markers of primary mesothelial cells","author":"Kanamori-Katayama","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2018.11.009_bib76","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.1000843107","article-title":"Structural basis for Rab GTPase recognition and endosome tethering by the C2H2 zinc finger of Early Endosomal Autoantigen 1 (EEA1)","volume":"107","author":"Mishra","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfda.2018.11.009_bib77","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1073\/pnas.0901444106","article-title":"Sorting in early endosomes reveals connections to docking- and fusion-associated factors","volume":"106","author":"Barysch","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfda.2018.11.009_bib78","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1073\/pnas.88.24.10998","article-title":"Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease","volume":"88","author":"Cataldo","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfda.2018.11.009_bib79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2004.09.018","article-title":"Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases","volume":"26","author":"Nixon","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jfda.2018.11.009_bib80","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/ncomms3250","article-title":"Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system","volume":"4","author":"Morel","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jfda.2018.11.009_bib81","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.jfda.2018.11.009_bib82","doi-asserted-by":"crossref","first-page":"50476","DOI":"10.18632\/oncotarget.9919","article-title":"Inhibition of PI3K\/Akt\/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis","volume":"8","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jfda.2018.11.009_bib83","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.febslet.2005.02.048","article-title":"Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the PI3-kinase\/Akt pathway in cultured Ra2 microglial cells","volume":"579","author":"Ito","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jfda.2018.11.009_bib84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2010.05.079","article-title":"Neuroprotective effects of emodin in rat cortical neurons against beta-amyloid-induced neurotoxicity","volume":"1347","author":"Liu","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.jfda.2018.11.009_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00702-012-0852-5","article-title":"Different effects of soluble and aggregated amyloid beta42 on gene\/protein expression and enzyme activity involved in insulin and APP pathways","volume":"120","author":"Bartl","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jfda.2018.11.009_bib86","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1172\/JCI98199","article-title":"Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome","volume":"128","author":"Hacohen-Kleiman","year":"2018","journal-title":"J Clin Invest"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949819300109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949819300109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949819300109?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T14:19:56Z","timestamp":1666621196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1021949819300109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1021949819300109"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2018.11.009","relation":{},"ISSN":["1021-9498"],"issn-type":[{"value":"1021-9498","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of aluminum ion neurotoxicity through a small peptide application \u2013 NAP treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}